Cargando…
Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer
Radiotherapy treatment planning (RTP) is time-consuming and labor-intensive since medical physicists must devise treatment plans carefully to reduce damage to tissues and organs for patients. Previously, we proposed the volume-based algorithm (VBA) method, providing optimal partial arcs (OPA) angle...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847643/ https://www.ncbi.nlm.nih.gov/pubmed/35169144 http://dx.doi.org/10.1038/s41598-021-04571-3 |
_version_ | 1784652088959041536 |
---|---|
author | Hsu, Chen-Xiong Lin, Kuan-Heng Wang, Shan-Ying Tsai, Wei-Ta Chang, Chiu-Han Tien, Hui-Ju Shueng, Pei-Wei Wu, Tung-Hsin Mok, Greta S. P. |
author_facet | Hsu, Chen-Xiong Lin, Kuan-Heng Wang, Shan-Ying Tsai, Wei-Ta Chang, Chiu-Han Tien, Hui-Ju Shueng, Pei-Wei Wu, Tung-Hsin Mok, Greta S. P. |
author_sort | Hsu, Chen-Xiong |
collection | PubMed |
description | Radiotherapy treatment planning (RTP) is time-consuming and labor-intensive since medical physicists must devise treatment plans carefully to reduce damage to tissues and organs for patients. Previously, we proposed the volume-based algorithm (VBA) method, providing optimal partial arcs (OPA) angle to achieve the low-dose volume of lungs in dynamic arc radiotherapy. This study aimed to implement the VBA for esophageal cancer (EC) patients and compare the lung dose and delivery time between full arcs (FA) without using VBA and OPA angle using VBA in volumetric modulated arc therapy (VMAT) plans. We retrospectively included 30 patients diagnosed with EC. RTP of each patient was replanned to 4 VMAT plans, including FA plans without (FA-C) and with (FA + C) dose constraints of OARs and OPA plans without (OPA-C) and with (OPA + C) dose constraints of OARs. The prescribed dose was 45 Gy. The OARs included the lungs, heart, and spinal cord. The dose distribution, dose-volume histogram, monitor units (MUs), delivery time, and gamma passing rates were analyzed. The results showed that the lung V(5) and V(10) in OPA + C plans were significantly lower than in FA + C plans (p < 0.05). No significant differences were noted in planning target volume (PTV) coverage, lung V(15), lung V(20), mean lung dose, heart V(30), heart V(40), mean heart dose, and maximal spinal cord dose between FA + C and OPA + C plans. The delivery time was significantly longer in FA + C plans than in OPA + C plans (237 vs. 192 s, p < 0.05). There were no significant differences between FA + C and OPA + C plans in gamma passing rates. We successfully applied the OPA angle based on the VBA to clinical EC patients and simplified the arc angle selection in RTP. The VBA could provide a personalized OPA angle for each patient and effectively reduce lung V(5), V(10,) and delivery time in VMAT. |
format | Online Article Text |
id | pubmed-8847643 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88476432022-02-17 Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer Hsu, Chen-Xiong Lin, Kuan-Heng Wang, Shan-Ying Tsai, Wei-Ta Chang, Chiu-Han Tien, Hui-Ju Shueng, Pei-Wei Wu, Tung-Hsin Mok, Greta S. P. Sci Rep Article Radiotherapy treatment planning (RTP) is time-consuming and labor-intensive since medical physicists must devise treatment plans carefully to reduce damage to tissues and organs for patients. Previously, we proposed the volume-based algorithm (VBA) method, providing optimal partial arcs (OPA) angle to achieve the low-dose volume of lungs in dynamic arc radiotherapy. This study aimed to implement the VBA for esophageal cancer (EC) patients and compare the lung dose and delivery time between full arcs (FA) without using VBA and OPA angle using VBA in volumetric modulated arc therapy (VMAT) plans. We retrospectively included 30 patients diagnosed with EC. RTP of each patient was replanned to 4 VMAT plans, including FA plans without (FA-C) and with (FA + C) dose constraints of OARs and OPA plans without (OPA-C) and with (OPA + C) dose constraints of OARs. The prescribed dose was 45 Gy. The OARs included the lungs, heart, and spinal cord. The dose distribution, dose-volume histogram, monitor units (MUs), delivery time, and gamma passing rates were analyzed. The results showed that the lung V(5) and V(10) in OPA + C plans were significantly lower than in FA + C plans (p < 0.05). No significant differences were noted in planning target volume (PTV) coverage, lung V(15), lung V(20), mean lung dose, heart V(30), heart V(40), mean heart dose, and maximal spinal cord dose between FA + C and OPA + C plans. The delivery time was significantly longer in FA + C plans than in OPA + C plans (237 vs. 192 s, p < 0.05). There were no significant differences between FA + C and OPA + C plans in gamma passing rates. We successfully applied the OPA angle based on the VBA to clinical EC patients and simplified the arc angle selection in RTP. The VBA could provide a personalized OPA angle for each patient and effectively reduce lung V(5), V(10,) and delivery time in VMAT. Nature Publishing Group UK 2022-02-15 /pmc/articles/PMC8847643/ /pubmed/35169144 http://dx.doi.org/10.1038/s41598-021-04571-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hsu, Chen-Xiong Lin, Kuan-Heng Wang, Shan-Ying Tsai, Wei-Ta Chang, Chiu-Han Tien, Hui-Ju Shueng, Pei-Wei Wu, Tung-Hsin Mok, Greta S. P. Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer |
title | Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer |
title_full | Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer |
title_fullStr | Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer |
title_full_unstemmed | Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer |
title_short | Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer |
title_sort | planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in vmat for esophageal cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847643/ https://www.ncbi.nlm.nih.gov/pubmed/35169144 http://dx.doi.org/10.1038/s41598-021-04571-3 |
work_keys_str_mv | AT hsuchenxiong planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT linkuanheng planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT wangshanying planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT tsaiweita planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT changchiuhan planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT tienhuiju planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT shuengpeiwei planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT wutunghsin planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer AT mokgretasp planningevaluationofanovelvolumebasedalgorithmforpersonalizedoptimizationoflungdoseinvmatforesophagealcancer |